![](https://www.pdfsearch.io/img/4ad9ade545541059e4df7888d5e1cdfa.jpg) Date: 2017-10-03 19:39:49
| | Visterra’s Monoclonal Antibody in Development for the Treatment of Influenza A, VIS410, Demonstrated Significant Antiviral Activity and Reduced Duration of Respiratory Symptoms in Phase 2a Challenge Study – Study AchAdd to Reading ListSource URL: visterrainc.comDownload Document from Source Website File Size: 127,86 KBShare Document on Facebook
|